VANECK VECTORS ETF TR's ticker is GDX and the CUSIP is 92189F106. A total of 455 filers reported holding VANECK VECTORS ETF TR in Q2 2019. The put-call ratio across all filers is 0.71 and the average weighting 0.5%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $17,010,995 | -17.6% | 632,144 | -7.8% | 0.05% | -16.4% |
| Q2 2023 | $20,654,918 | -1.8% | 685,982 | +5.5% | 0.06% | +5.8% |
| Q1 2023 | $21,030,509 | +135423.3% | 650,093 | +20.1% | 0.05% | +26.8% |
| Q4 2022 | $15,518 | -99.9% | 541,444 | +11.6% | 0.04% | +20.6% |
| Q3 2022 | $11,699,000 | -26.9% | 485,030 | -17.0% | 0.03% | -22.7% |
| Q2 2022 | $16,005,000 | -6.3% | 584,562 | +31.2% | 0.04% | +4.8% |
| Q1 2022 | $17,090,000 | +19.9% | 445,637 | +0.2% | 0.04% | +27.3% |
| Q4 2021 | $14,251,000 | -1.7% | 444,929 | -9.6% | 0.03% | -10.8% |
| Q3 2021 | $14,503,000 | -18.5% | 492,130 | -6.1% | 0.04% | -19.6% |
| Q2 2021 | $17,803,000 | +13.4% | 523,911 | +8.5% | 0.05% | +4.5% |
| Q1 2021 | $15,698,000 | -21.4% | 483,007 | -12.9% | 0.04% | -26.7% |
| Q4 2020 | $19,983,000 | -25.5% | 554,771 | -19.0% | 0.06% | -34.8% |
| Q3 2020 | $26,819,000 | +42.1% | 684,844 | +33.1% | 0.09% | +29.6% |
| Q2 2020 | $18,867,000 | +65.5% | 514,348 | +3.9% | 0.07% | +36.5% |
| Q1 2020 | $11,403,000 | -19.0% | 494,931 | +3.0% | 0.05% | +2.0% |
| Q4 2019 | $14,075,000 | -56.0% | 480,718 | -59.9% | 0.05% | -59.5% |
| Q3 2019 | $32,015,000 | +2.9% | 1,198,619 | -1.6% | 0.13% | +4.1% |
| Q2 2019 | $31,119,000 | +226.0% | 1,217,504 | +185.9% | 0.12% | +116.1% |
| Q1 2019 | $9,546,000 | +6.3% | 425,799 | -0.0% | 0.06% | -8.2% |
| Q4 2018 | $8,982,000 | +24.3% | 425,897 | +9.3% | 0.06% | +35.6% |
| Q3 2018 | $7,226,000 | -22.3% | 389,541 | -6.5% | 0.04% | -28.6% |
| Q2 2018 | $9,296,000 | -2.3% | 416,654 | -3.7% | 0.06% | -6.0% |
| Q1 2018 | $9,513,000 | +1.5% | 432,788 | +7.3% | 0.07% | +1.5% |
| Q4 2017 | $9,377,000 | -49.9% | 403,475 | -50.5% | 0.07% | -53.2% |
| Q3 2017 | $18,734,000 | +143.3% | 815,919 | +133.9% | 0.14% | +135.0% |
| Q2 2017 | $7,701,000 | +13.5% | 348,769 | +17.3% | 0.06% | +9.1% |
| Q1 2017 | $6,784,000 | +36.1% | 297,398 | +24.8% | 0.06% | +27.9% |
| Q4 2016 | $4,984,000 | -36.0% | 238,224 | -19.1% | 0.04% | -38.6% |
| Q3 2016 | $7,787,000 | +2.1% | 294,630 | +8.2% | 0.07% | 0.0% |
| Q2 2016 | $7,624,000 | – | 272,246 | – | 0.07% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Memorial Sloan Kettering Cancer Center | 738,500 | $19,873,035 | 80.92% |
| New Harbor Financial Group, LLC | 1,680,752 | $45,229,033 | 14.96% |
| TORQ CAPITAL MANAGEMENT (HK) Ltd | 139,000 | $3,740,490 | 9.95% |
| Vanderbilt University | 1,360,540 | $36,612,131 | 9.45% |
| Eschler Asset Management LLP | 300,000 | $8,073,000 | 9.42% |
| New Harbor Financial Group, LLC | 1,027,300 | $27,644,643 | 9.15% |
| Guild Investment Management, Inc. | 139,333 | $3,749,454 | 6.28% |
| Monaco Asset Management SAM | 750,000 | $20,182,500 | 5.98% |
| STRATEGIC INVESTMENT MANAGEMENT, LLC | 132,460 | $3,867,832 | 4.74% |
| PCG Wealth Advisors, LLC | 264,614 | $7,120,782 | 4.67% |